Effectively Measuring The Functional Capacity Of Individuals With Serious Mental Illness
Accurately measuring functional assessment in individuals with serious mental illness (SMI) is important. This is especially true in the case of clinical trials that aim to improve individuals’ cognitive impairment and negative symptoms through new compounds, and particularly for individuals with schizophrenia; the U.S. Food and Drug Administration requires improvement in functional outcome as a co-primary measure in these types of investigations. However, assessing functional outcomes of people with SMI is challenging for a variety of reasons according to Matt …